Daily FNArena News - Small Caps
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure ChestPrevious Stories
Dr Boreham’s Crucible: Blinklab
May 20 2024
Recently ASX-listed Blinklab claims the world’s best mobile phone app for detecting autism, the New Criterion’s Tim Boreham reports
Premium ARB Corp Keeps Delivering The Goods
May 16 2024
ARB Corp’s third-quarter performance showcased why shares continue to trade at a premium to the Small Industrials Index
FleetPartners Green Outlook Is Electrifying
May 15 2024
Following a strong run over the last year, brokers see further upside for shares of FleetPartners following first half results
More Life Left In Life360
May 14 2024
Life360 has doubled in share price since its March earnings result, but brokers believe further re-rating is still on the cards
Dr Boreham’s Crucible: Invion
May 13 2024
As per the New Criterion’s Tim Boreham, Invion is an old company on a new mission
SiteMinder Travelling Well
May 01 2024
SiteMinder’s March quarter update showed the company is on track to reach positive earnings and cash flow next quarter and new product launches offer growth
Dr Boreham’s Crucible: 4D Medical
Apr 23 2024
The New Criterion’s Tim Boreham uncovers the potential of 4D Medical in the USA
Dr Boreham’s Crucible: Race Oncology
Apr 09 2024
Race Oncology tells a story all too familiar among developing Aussie biotechs, Tim Boreham reports
And Now For Something Different: Royalties
Apr 02 2024
The New Criterion’s Tim Boreham explains the benefits of royalties and where to access them via the ASX
Dr Boreham’s Crucible: Hydrix
Mar 26 2024
Tim Boreham highlights Hydrix as one of the most innovative small-cap healthcare companies on the ASX
